These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 24941992)
21. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994 [TBL] [Abstract][Full Text] [Related]
22. Fine-needle aspiration of metastatic clear cell carcinoma of the kidney: employment of microdissection and the polymerase chain reaction as a potential diagnostic tool. Beaty MW; Zhuang Z; Park WS; Emmert-Buck MR; Linehan WM; Lubensky IA; Abati A Cancer; 1997 Jun; 81(3):180-6. PubMed ID: 9196017 [TBL] [Abstract][Full Text] [Related]
23. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus. Lawindy SM; Kurian T; Kim T; Mangar D; Armstrong PA; Alsina AE; Sheffield C; Sexton WJ; Spiess PE BJU Int; 2012 Oct; 110(7):926-39. PubMed ID: 22540179 [TBL] [Abstract][Full Text] [Related]
24. The expanding role of imaging in the management of renal cell carcinoma. Murphy G; Jhaveri K Expert Rev Anticancer Ther; 2011 Dec; 11(12):1871-88. PubMed ID: 22117155 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications. Gabril M; White NM; Moussa M; Chow TF; Metias SM; Fatoohi E; Yousef GM Biol Chem; 2010 Apr; 391(4):403-9. PubMed ID: 20128686 [TBL] [Abstract][Full Text] [Related]
26. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset. Greco FA; Hainsworth JD Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002 [TBL] [Abstract][Full Text] [Related]
28. Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites. Steiner G; Sidransky D Am J Pathol; 1996 Dec; 149(6):1791-5. PubMed ID: 8952515 [TBL] [Abstract][Full Text] [Related]
29. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations. Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524 [TBL] [Abstract][Full Text] [Related]
30. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma. Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199 [TBL] [Abstract][Full Text] [Related]
31. Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation. Ku JH; Park YH; Myung JK; Moon KC; Kwak C; Kim HH Urol Oncol; 2011; 29(6):731-7. PubMed ID: 19914104 [TBL] [Abstract][Full Text] [Related]
33. [Possibilities of molecular diagnosis of renal cell carcinoma]. Junker K Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022 [TBL] [Abstract][Full Text] [Related]
34. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841 [TBL] [Abstract][Full Text] [Related]